Poison center joins snake antivenom study
The Arizona Poison and Drug Information Center is now participating in a phase III clinical trial for an investigational rattlesnake antivenom from Mexico called Anavip. The study will compare its effectiveness and safety against the currently FDA approved CroFab.
Sections:
